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Harmsiopanax aculeatus leaves, a medicinal plant with locally named 
kapur, have been used traditionally to treat malaria in Maluku, Indonesia. 
However, the scientific information of this plant is still limited. In our 
previous study, the methanol extract of this plant leaves have been proven 
to possess in vitro antiplasmodial activity. This study was conducted to 
evaluate in vitro antiplasmodial activity and cytotoxicity of  subfractions of 
the plant leaves. Fractionation was performed using a column 
chromatography with Sephadex LH-20 as the  stationary phase and 
methanol as the mobile phase. The subfractions obtained were then tested 
for in vitro antiplasmodial activity on a chloroquine-resistant FCR3 strain of 
Plasmodium falciparum using a visual method. Cytotoxicity was evaluated by 
using MTT assay. The in vitro antiplasmodial activity and cytotoxicity were 
expressed as IC50, calculated using probit analysis with SPSS 16 for windows. 
The results showed that the four subfractions tested have a high 
antiplasmodial activity with IC50 values of 0.09; 0.18; 0.01; and 0.77 µg.mL-1, 
respectively. In addition, these subfractions had IC50 values of >400 µg.mL-1 
against Vero cells indicating that they were non-toxic. In conclusion, the 
subfractions of H. aculeatus leaves are very active and selective against P. 
falciparum. Further study will be conducted to isolate the active compounds. 





Although the number of malaria cases 
declined by 20% in the last decade,  malaria is still 
one of the major public health problem worldwide, 
especially in tropical countries including Indonesia. 
In 2017, an estimated 219 million new malaria 
cases occurred with 435,000 deaths from malaria 
globally. Most malaria cases were in the African 
Region (92%), followed by the Southeast Asian 
Region (5%) and the Eastern Mediterranean 
Region (2%) (WHO, 2018). 
Resistance to the first-line antimalarial 
drugs especially chloroquine is one of the major 
problems in malaria eradication. Currently, the 
World Health Organization (WHO) recommended 
Artemisinin-based Combination Therapies (ACTs) 
as first- and second-line treatment for 
uncomplicated or chloroquine-resistant 
Plasmodium (WHO, 2010). However, after several 
years of use, resistance to artemisinin was first 
reported in Cambodia in 2009 and then emerged 
Laos, Myanmar, Thailand and Vietnam (Fairhurst & 
Dondorp, 2016; Fairhurst, 2016; Wells et al., 2015). 
The resistance to antimalarial drugs has 
encouraged the academia and the pharmaceutical 
industry to discover and develop new antimalarial 
drugs. Some strategies have been implemented 
through chemotype screening or identification of 
Antiplasmodial Activity and Cytotoxicity of  Active Sub-Fraction of Harmsiopanax aculeatus Leaves 
52   Volume 31 Issue 1 (2020) 
synthetic target molecules in the laboratory and 
computationally, as well as through screening of 
natural resources (Wells et al., 2015).  
Many medicinal plants traditionally used to 
treat malaria from various regions were evaluated 
for their potential antiplasmodial activity. 
Harmsiopanax aculeatus leaves, locally named 
kapur, have been used to treat malaria in Maluku, 
Indonesia. Previous studies were reported that 
methanol extract of H. aculeatus leaves has in vitro 
and in vivo antiplasmodial activity and it is not toxic 
in Vero cells line (Turalely et al., 2018; Turalely et 
al., 2011). Furthermore, among 12 fractions 
obtained from the methanol extract using 
chloroform-ethyl acetate (8:2), the fraction FG7 
showed the most active fraction. In this study, we 
reported antiplasmodial activity and cytotoxicity of 
subfractions of the active fraction FG7.  
 
MATERIAL AND METHODS 
Materials 
The samples of plant leaf were collected 
from Amahai Village, Amahai District, Central 
Maluku Regency, Maluku, Indonesia and 
determined in the Taxonomy Laboratory, Faculty of 
Biology, Universitas Gadjah Mada, Yogyakarta, 
Indonesia as Harmsiopanax aculeatus (Blume) 
Warb. Ex Boerl (Araliaceae, Voucher number 1 
HaA). The primary materials used for fractionation 
were Sephadex LH-20 (Sigma), dissolved fraction 
in chloroform-ethyl acetate (8: 2), chloroform, 
methanol, and ethyl acetate (E-Merck), and thin-
layer chromatography (TLC) plates. The primary 
materials for the in vitro antiplasmodial activity 
test were RPMI, red blood cells, Plasmodium 
falciparum strain FCR3, DMSO, human serum, and 
Giemsa. The primary materials for the cytotoxicity 
activity test were Vero cells, M199 media, DMSO, 
and MTT. The flavonoid test in the most active 
subfraction was carried out using a FeCl3 spray 
reagent. 
 
Fractionation of dissolved fractions in 
chloroform-ethyl acetate (8:2) 
The dissolved fraction in chloroform-ethyl 
acetate (8:2) was fractionated using column 
chromatography with LH-20 as the stationary 
phase (Figure 1). The mobile phase used was 100% 
methanol. Thirty g of Sephadex LH-20 was soaked 
in methanol for 24h. Furthermore, columns 
measuring 1.5cm in diameter and 50cm in length, 
were packed using the Sephadex which had soaked 
up to ¾ of the column. Subsequently, the test 
material was dissolved using methanol and loaded 
on to the column. Elution was carried out using 
100% methanol. Each fraction was collected at a 
flow rate of 2mL.min-1. The collected fraction was 
monitored by TLC. Fractions with the same TLC 
profile were combined. Each fraction obtained was 





Figure 1. Scheme of the experimental procedure 
 
In vitro antiplasmodial activity assay  
In vitro antiplasmodial activity of each 
sufraction was tested against the chloroquine-
resistant P. falciparum strain (FCR3) obtained from 
continuous cultured using a visual method. The 
Plasmodium was cultured using candle jar method 
according to Trager and Jensen (1976) after 
modification. One hundred µL of the Plasmodium 
culture in ring stage, after synchronized with 
sorbitol 5%, in a final 2% haematocrit and 0.5% 
parasitemia. was added into the wells of 96-well 
microtitre plate. Eight varies concentrations 
different of subfractions solution ranging from 
0.005 to 60 μg.mL-1, depend on each fraction, were 
prepared using culture medium. One hundred µL of 
the sufraction solution was then added in the wells 
in triplicate. The microtitre plate were placed in a 
candle jar and incubated at 37°C for 72h in a CO2 
incubator. The wells containing culture medium 
without subfraction were used as negative control. 
Followed after incubation, a thin blood smear of 
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each wells was prepared and then Giemsa staining 
was conducted. Parasitemia of each the Giemsa 
stained thin blood smears was observed 
microscopically to calculate the Plasmodium 
growth. Inhibitory concentration 50% (IC50) or 
concentration that inhibit 50% Plasmodium 
growth, was determined using probit analysis with 
SPSS 16 for windows and used to express the 
antiplasmodial activity.              
 
Cytotoxicity activity assay 
The cytotoxicity of the subfractions on Vero 
cells line (M199) was tested using a MTT method 
assay method. Six varies concentrations different of 
subfractions solution ranging from 15.625 to 
1000μg.mL-1 were prepared using culture medium. 
One hundred µL of the cells culture and 100µL of 
the subfraction solutions were added into the      
wells of 96-well microtitre plate. The microtitre 
plate were incubated at 37°C for 24h in a CO2 
incubator. Each subfraction was tested in triplicate 
in three independent experimental. The wells 
containing medium culture without subfraction 
was used as negative control. Followed after 
incubation, cells medium was removed from            
the wells and 25µL of the MTT solution (2mg/mL  
in PBS) was added to each well. The microtitre 
plate was incubated at 37°C for 1.5h and 125µL        
of DMSO was added to each well to dissolve the 
purple formazan crystals. The absorbance of each 
well was measured using an ELISA reader at 
595nm. The cytotoxicity was expressed as IC50 
calculated using probit analysis with SPSS 16 for 
windows.   
  
Phytochemical identification of the most active 
subfractions 
Identification of flavonoid compounds in the 
most active subfractions was carried out using 
FeCl3 spray reagents. 
 
RESULT AND DISCUSSION 
Four subfractions were obtained from 
fractionation of 0.026g active fraction of 
Table I. Subfractions of H. aculeatus chloroform-ethyl acetate fraction and their TLC profiles 
 





(λ 254 nm) 
UV  




0.39 0.86; 0.97 - Green fluorescent Blue fluorescent 




37.50 0.89 - Green fluorescent Blue fluorescent 
4 SF.4 Greenish powder 23.44 0.79; 0.89 - Green fluorescent Blue fluorescent 
 
 
Table II. Plasmodium growth inhibition and antiplasmodial activity of subfractions of H. aculeatus 
 
Subfraction  1 (SF.1) Subfraction 2 (SF.2) Subfraction 3 (SF.3) Subfraction 4 (SF.4) 
Conc.  
(µg/mL) 














60 94.89±2.87 100 78.46±15.68 20 92.05±2.93 20 85.6±3.55 
50 94.54±3.98 50 68.97±9.09 10 74.89±4.76 10 65.22±2.72 
25 91.57±3.54 10 61.25±7.38 5 67.09±2.21 5 63.14±4.21 
20 86.36±12.33 5 58.87±13.97 1 66.14±5.54 0.5 58.61±5.12 
10 73.01±4.83 1 55.23±5.85 0.5 64.67±3.00 0.05 54.37±3.45 
5 62.89±2.76 0.5 52.89±8.18 0.1 63.57±2.66 0.005 42.48±5.36 
1 57.61±8.40 0.1 46.85±3.57 0.05 62.73±4.94   
0.5 53.53±12.26 0.05 44.67±9.11 0.01 49.86±11.81   
0.1 49.88±4.56 0.01 41.46±6.96     
0.05 42.68±13.86 0.005 39.15±10.71     
IC50 (µg.mL-1) 0.22  0.57  0.01  0.04 
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chloroform-ethyl acetate. The form and TLC profile 
of the subfractions (Table I). The inhibition of 
Plasmodium growth and in vitro antiplasmodial 
activity (IC50) of the subfractions of H. aculeatus 
leaves (Table II), whereas their cytotoxicity and 
index selectivity (IS) (Table III). 
 
Table III. Cytotoxicity and selectivity index of  
subfractions of H. aculeatus  
 
Subfraction 




SF7.1 >700 >7692.31 
SF7.2 408.80 2271.11 
SF7.3 >1000 >125,000 
SF7.4 1022.44 131.93 
 
Antiplasmodial activity of natural products 
or synthetic compounds can be categorized into 
high if the IC50 value ˂5 μg.mL-1; promising if the 
IC50 value between 5-15 μg.mL-1, moderate if the 
IC50 value between 15-50 μg.mL-1 and, not active if 
the IC50 value >50 μg.mL-1 (Jonville et al., 2008). 
Based on this criteria, all of the subfractions tested 
showed high antiplasmodial activity with the IC50 
value <5 μg.mL-1 (Table 2). The highest 
antiplasmodial activity was obtained from the SF.3 
with IC50 value of 0.01 μg.mL-1. Furthermore, all of 
the subfractions had IC50 value lower than it’s the 
parent extract or fraction (methanol extract or  
chloroform-ethyl acetate fraction) that reported in 
the previous study (Turalely et al., 2018). It is 
indicated that the all of the subfractions have 
higher antiplasmodial activity than the parent 
extract or fraction.   
Cytotoxicity of compounds can be 
categorized non-toxic to mammalian cells if the 
IC50 >30 μg.mL-1 (Nondo et al., 2017). Based on this 
criteria, all of the subfractions tested showed non-
toxic. The IC50 value of the all of fractions >30 
μg.mL-1 ranging from 408.80 to >1000 (Table 3). 
The all of fractions also showed high selective as 
demonstrated with the IS value ranged from 131.93 
to >125,000 (Table 3). The highest selectivity was 
obtained from the SF.3 with IC50 value >125,000 
μg.mL-1. Base on the SI value, the SF.3 is the most 
potential fractions to be isolated its active 
antiplasmodial compounds. 
The antiplasmodial activity of Indonesian 
medicinal plants have been reported in the 
previous studies. The Eurycoma longifolia (pasak 
bumi) extracts were reported to have 
antiplasmodial activity with IC50 value ranged 
2.21-19.02 μg.mL-1 (Sholikhah et al., 2018). In 
addition, Lyles et al. (2014) reported 
antiplasmodial activity of a mixture of 
benzophenones and xanthones of edible fruit from 
Garcinia species with IC50 value >2 μg.mL-1.  The 
antiplasmodial activity of the subfractions tested in 
this study was higher than that from the two 
medicinal plants previously reported. It was 
indicated that the active subfractions of the H. 
aculeatus is very promising to be further explored 
for its antimalarial active compounds. 
Phytochemical studies of H. aculeatus are 
very limited. The antiplasmodial active compounds 
of this plant have not been isolated and identified. 
In the previous studies, flavonoids contain were 
reported in the methanol extract and the active 
fraction (Turalely et al., 2011; 2012). In this study, 
the flavonoids were also identified in the SF.3.             
It is indicted that the flavonoids may be responsible 
for the antiplasmodial activity of this subfraction. 
The antiplasmodial activity of flavonoids isolated 
from medicinal plants was reported. 
Tetrahydroxyxanthone was reported to have 
antimalarial activity (Ignatushchenko et al., 2000), 
whereas Lyles et al. (2014) also reported in vitro 
antiplasmodial activity of another xanthones from 
another plant.  
 
CONCLUSION 
The four subfractions of H. aculeatus leaves 
tested have high in vitro antiplasmodial activity and 
selectivity against P. falciparum. Further study will 
be focused to isolate and identify active 
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